Also rapid administration may possibly result in respiratory despair, laryngospasm, apnea, or vasodilation with tumble in blood pressure level
You signed in with One more tab or window. Reload to refresh your session. You signed out in An additional tab or window. Reload to refresh your session. You switched accounts on A different tab or window. Reload to refresh your session.
pentobarbital will decrease the extent or outcome of nisoldipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will reduce the level or influence of alosetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Not known.
With therapeutic doses of TCAs, barbiturates improve metabolism and decrease blood concentrations of TCAs.
pentobarbital will decrease the level or impact of tofacitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Loss of, or reduced response to tofacitinib could arise when coadministered with powerful CYP3A4 inducers
pentobarbital will lower the level or effect of fedratinib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Outcome of coadministering a powerful CYP3A4 inducer with fedratinib has not been researched.
Keep an eye on Intently (1)pentobarbital will reduce the extent or influence of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will reduce the extent or influence of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Strong CYP3A4 inducers may well lessen partiaprevir and ritonavir amounts, and therefore diminished efficacy of Viekira Pak
pentobarbital will lower the extent or effect 戊巴比妥鈉製作 of levoketoconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.
pentobarbital will reduce the extent or result of brexpiprazole by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Closely. Double brexpiprazole dose about 1-two weeks if administered with a robust CYP3A4 inducer.
pentobarbital will minimize the level or influence of lopinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lessen the extent or result of vinblastine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Small/Significance Unknown.
pentobarbital will minimize the level or result of linagliptin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Use of other remedies is strongly advisable when linagliptin is to be administered using a CYP3A4 inducer